Monica Rosa Miozzo

Expert in medical genetics, genomics, epigenomics and rare diseases

Role

Full Professor of Medical Genetics at the Department of Health Sciences, University of Milan; Director of the Complex Unit of Medical Genetics at the ASST Santi Paolo e Carlo in Milan; Director of the School of Specialization in Medical Genetics, Università degli Studi di Milano (since 2022).

Bio

After graduating in Biological Sciences in 1987, she specialized in Medical Genetics and obtained a PhD in Cellular and Molecular Biology from the Università degli Studi di Milano. She began her career as an AIRC researcher at the National Cancer Institute of Milan (1987–1994), before continuing her academic career at the Università degli Studi di Milano, where she has been a full professor of Medical Genetics since 2018 and directs the School of Specialization in Medical Genetics. At the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico in Milan, she directed the Research Laboratory Coordination Unit, Genomics and Bioinformatics Platform (2011–2021).

His research interests include genomic and epigenomic alterations, genetic predisposition to tumors (solid and hematological), rare diseases caused by imprinting defects, pharmacogenetics and personalized medicine, and aerospace medicine.

He participated in the Virtute I Mission – Virgin Galactic, June 2023 (Spaceport America, New Mexico): as part of the collaboration with the Air Force Health Service.

A Visiting Professor at Columbia University in New York (Motor Neuron Center, Mailman School of Public Health, 2019), she has authored over 160 publications in international scientific journals (Scopus, October 2026: 9012 citations, H-index 49). An Academic Editor of PLoS ONE since 2014, in 2009 she was awarded the Isimbardi Prize by the Province of Milan for her scientific and teaching activity.

Main research projects (2021–2026)

  • 2022–2026: Complementary PNRR – D3-4Health. Digital-Driven Diagnostics, Pronostics, and Therapeutics for Sustainable Health Care. PI Spoke 1, University of Milan
  • 2021–2024: Ministry of Defense; National Military Research Plan (PNRM) – TORNADO: Omics Techniques and Neural Networks for Predictive Risk Models. PI, UniMI Unit

Main institutional roles

  • 2020 – present: Member of the Territorial Ethics Committee of Lombardy 4, expert in medical genetics
  • 2023 – 2015: Coordinator of the Pharmacogenomics Working Group and Member of the Epigenomics Working Group, SIGU
  • 2020 – present: Member of the Scientific Committee of FAST-Italia (Angelman Syndrome Patients Association)
  • 2025-present: Board Member of SIGU (Italian Society of Human Genetics)